Cadence Pharmaceuticals™

Investor Relations

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recent Releases

Jul 29, 2010
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2010 Financial Results on August 5, 2010

Jul 27, 2010
Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of August 2010

Events

Aug 13, 2010
Bank of America Merrill Lynch Specialty Pharmaceuticals Conference

Aug 12, 2010
Canaccord Genuity 30th Annual Growth Conference 2010

more »

Print page Print
Email page Email


Stock Quote
CADX - (NASDAQ)
$7.28   - 0.03
Jul 29, 2010
4:00 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.